The Valley Desk

NCT03809624 · Interventional trial

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Overall registry status Terminated

Phase 1

Conditions Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Head and Neck Squamous Cell Carcinoma, Melanoma, Metastatic Solid Tumors, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, Oropharyngeal Carcinoma, Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov